Cervical cancer screening concerns in Balkans

In mid‑July 2026 a Serbian woman’s experience highlighted the limits of Pap smear testing when she developed stage III cervical cancer despite prior normal results. Medical experts explained that false‑negative outcomes can occur if abnormal cells are located deeper in the cervical canal, underscoring the need for complementary procedures such as colposcopy and biopsy.

Later that month, Romanian health authorities responded to online misinformation that claimed the Pap smear itself causes cancer. The National Institute of Public Health clarified that the test is a preventive tool that detects precancerous changes and poses no health risk. Officials also promoted HPV testing as an additional screening method, recommending three‑year intervals for women with negative results. Together, the two reports illustrate a regional focus on both the technical reliability of cervical cancer screening and the public‑health effort to counter false information and encourage regular testing.